GSK Pays $3 Billion to Settle Drug Promotion ChargesJuly 2, 2012DiabetesPediatricsEndocrinologyMental HealthBusiness of Medicine
Despite Cardiac Concerns, FDA OKs Obesity Drug LorcaserinJune 27, 2012DiabetesObesityCardiologyEndocrinologyGastroenterology
